SEC Form 4 · accession 0001654954-18-006742
TG THERAPEUTICS, INC. · TGTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William James Kennedy
Director
Period of report
Jun 14, 2018
Accepted (ET)
Jun 18, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jun 14, 2018 | S | 25,071 | $13.45 | D | 60,330 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes shares of restricted Common Stock, which vest over various time periods.